Croatia Pharmaceuticals & Healthcare Q2 2020
Growth in the Croatian pharmaceutical market will accelerate slightly 2020, boosted by lower costs of non-prescriptionmedicine following VAT reductions on OTC products in 2019. In the coming years, we expect all segments of the market to graduallyslow, impeded by constrained government expenditure on healthcare. The rising cost of healthcare as the population ages will seethe government maintain a focus on cost containment measures, limiting the market’s potential over the long term.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook